However, upanap-126 significantly affected tumor cell intravasation and dissemination in vivo due to the inhibition of pro-uPA activation, competing with the binding of pro-uPA to uPAR and preventing the binding of the pro-uPAR/uPAR complex to the glycoprotein vitronectin [20]. Here, PLAU is linked to neoplasm.